Study of nose and throat reveals why people with COVID-19 may lose their sense of smell
Researchers studying tissue removed from patients’ noses during surgery believe they may have discovered the reason why so many people with COVID-19 lose their sense of smell, even when they have no other symptoms.
In their experiments they found extremely high levels of angiotensin converting enzyme II (ACE-2) only in the area of the nose responsible for smelling. This Enzyme is thought to be the ‘entry point’ that allows coronavirus to get into the cells of the body and cause an infection.
The researchers say their findings, published today (Wednesday) in the European Respiratory Journal , offer clues as to why COVID-19 is so infectious and suggest that targeting this part of the body could potentially offer more effective treatments.
The study was by Professor Andrew P. Lane, director of the division of rhinology and skull base surgery, and Dr Mengfei Chen, research associate, and colleagues from Johns Hopkins University School of Medicine, Baltimore, USA.
Professor Lane said: “I specialise in nasal and sinus problems, so the loss of the sense of smell in COVID-19 is of particular clinical interest to me. While other respiratory viruses generally cause loss of the sense of smell through obstruction of airflow due to swelling of the nasal passages, this virus sometimes causes loss of smell in the absence of other nasal symptoms.”
The team used tissue samples from the back of the nose of 23 patients, removed during endoscopic surgical procedures for conditions such as tumours or chronic rhinosinusitis, an inflammatory disease of the nose and sinus. They also studied biopsies from the trachea (windpipe) of seven patients. None of the patients had been diagnosed with coronavirus.
In the lab, the researchers used fluorescent dyes on the tissue samples to detect and visualise the presence of ACE2 under a microscope and compare levels of ACE2 in different cell types and parts of the nose and upper airway. 
They found by far the most ACE2 on the lining cells of the olfactory epithelium, the area at the back of the nose where the body detects smells. The levels of ACE2 in these cells was between 200 and 700 times higher than other tissue in the nose and trachea….
Image Credit: Amanda Scott/Envato
Thanks to Heinz V. Hoenen. Follow him on twitter: @HeinzVHoenen
News This Week
WEHI researchers are studying 'nanobodies' – tiny immune proteins made by alpacas—in a bid to understand whether they might be effective in blocking SARS-CoV-2, the virus that causes COVID-19. Alpacas produce unique antibodies—called nanobodies—that can [...]
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a [...]
A genetic modification in the ‘coat’ of a brain infection-causing virus may allow it to escape antibodies, according to Penn State College of Medicine researchers. They say testing people for this and other viral mutations [...]
Current chemotherapy regimens slow cancer progression and save lives, but these powerful drugs affect both healthy and cancerous cells. Now, researchers reporting in ACS' Nano Letters have designed DNA-based nanogels that only break down and [...]
The new technology behind Pfizer's and Moderna's coronavirus vaccines could be used to prevent everything from heart disease to cancer, experts say. The breakthrough vaccine 'platform' they use transforms the body into a virus-zapping vaccine [...]
Current state-of-the-art techniques have clear limitations when it comes to imaging the smallest nanoparticles, making it difficult for researchers to study viruses and other structures at the molecular level. Scientists from the University of Houston [...]
Virtual patients, vaccines, medicine-making biomachines and microneedles are examples of tech innovation that is meeting the moment to address the global health crisis. Health has been a strong focus for this year’s top 10 [...]
A Vancouver company is central to the news Monday morning that Pfizer is close to developing an effective vaccine against the coronavirus. Pfizer said Monday that an early peek at the data on its [...]
The first coronavirus vaccine can prevent more than 90% of people from getting Covid-19, a preliminary analysis shows. The developers - Pfizer and BioNTech - described it as a "great day for science and humanity". [...]
Researchers led by the University at Buffalo (UB) have devised a new method that could enhance the effectiveness of vaccines against the novel coronavirus, the virus that is responsible for causing COVID-19. Jonathan F. Lovell, PhD, an [...]
On March 17 this year, a man was taken to hospital in Israel suffering from a dry cough and a loss of sense of smell. He developed a fever and felt tired but, after three [...]
One of the world’s leading Covid-19 experimental vaccines produces an immune response in older adults as well as the young, its developers say, raising hopes of protection for those most vulnerable to the coronavirus that [...]
Coronavirus tests performed in labs are the gold standard for accuracy and antigen tests are a fast and inexpensive alternative. But backers of a third type of test, developed by a Nobel Prize winner [...]
COVID-19 is a severe infectious disease that has claimed >150,000 lives and infected millions in the United States thus far, especially the elderly population. Emerging evidence has shown the virus to cause hemorrhagic and immunologic [...]
Switzerland’s Covid-19 scientific taskforce chief says hospitals across the Alpine country could be swamped with new coronavirus cases in the next two or three weeks unless the situation improves. “We estimate that the capacity limit [...]